• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma

    2024-06-08 18:41:57MirkoMininiAllanPavyBouchraLekbabyLauraFouassier
    Hepatoma Research 2024年1期

    Mirko Minini, Allan Pavy, Bouchra Lekbaby, Laura Fouassier,2

    1Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris 75571, France.

    2Association pour l'étude des Cancers et Affections des voies Biliaires (ACABi), Saint-Cloud 92210, France.

    Abstract Cholangiocarcinoma (CCA) is a highly aggressive tumor of the biliary tree characterized by an intense desmoplastic tumor microenvironment (TME).To date, treatment of CCA remains challenging; tumor resection is the only curative treatment with a high recurrence probability.Besides resection, therapeutic options have moved forward with the advent of immunotherapies, but these remain limited and low effective.Our knowledge about the cellular interplays in CCA is still fragmentary.An area is currently emerging regarding the potential role of cancer cell plasticity in the genesis of an immunosuppressive microenvironment.The cancer cells’ ability to acquire stemness properties and to disseminate through an epithelial-mesenchymal transition (EMT) shape a tumor immune microenvironment that supports cancer progression by attracting immunosuppressive cells including myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), M2 macrophages, and by increasing the expression of inhibitory immune checkpoints such as PD-1/PD-L-1.EMT-inducing transcription factors (EMT-TF)have recently emerged as regulators of tumor immunity by creating an immunosuppressive microenvironment.This review delves into the molecular mechanisms underlying the existing links between EMT/stemness and tumor immune microenvironment, as well as the last discoveries in CCA.

    Keywords: Cancer cell plasticity, epithelial-mesenchymal transition, cancer stem cells, EMT-TF, immune evasion

    INTRODUCTION

    The great adaptability of cancer cells in nature confers cellular plasticity and heterogeneity inside the tumor[1].Cell plasticity in cancer is an adaptive mechanism irrespective of genetic alterations by which cancer cells modify their phenotype in response to external cues.Owing to cellular plasticity, cancer cells acquire pro-invasive capabilities and stem cell properties, stimulate an immunosuppressive microenvironment, and resist anti-cancer treatments.The best-known plasticity process is the EMT, which prompts cells to transition from an epithelial phenotype to a mesenchymal one, contributing to tumor progression and dissemination[2].Cells undergoing EMT can also acquire stemness traits favoring tumor persistence and drug resistance.Indeed, EMT is also considered a defense mechanism that endows cancer cells with an advantage in proliferation, motility, and resistance to drugs, including immunotherapies.Beyond current knowledge on cell plasticity, recent studies strongly indicate that this ability enables cancer cells to escape the immune system through mechanisms that start to be elucidated.Through cell plasticity,tumor cells contribute to the establishment of an immunosuppressive TME, limiting the immune control of the tumor[3].The interconnection between cell plasticity and immune evasion involves signals from cancer cells, and from both cellular and acellular components of TME.Among these signals, intracellular and extracellular factors already identified as major regulators of EMT and stemness contribute to abolishing the anti-immune response.Soluble factors such as the prototypal cytokine-induced EMT, transforming growth factor-β1 (TGF-β1), EMT-inducing transcription factors (EMT-TFs) including zinc finger E-box binding homeobox 1/2 (ZEB1/2), Snail family transcriptional repressor 1/2 (SNAI1/2) and TWIST family bHLH transcription factor 1/2 (TWIST 1/2), and epigenetic factors have been involved in the regulation of immune response in several carcinomas by remodeling the TME.The purpose of this review is to provide an overview of two major pathophysiological processes that are obviously intertwined in cancer, i.e., cell plasticity and immunobiology.

    EPITHELIAL-MESENCHYMAL TRANSITION AND TUMOR IMMUNE MICROENVIRONMENT

    EMT is a multi-step cellular plasticity program essential for embryonic development and organogenesis,which is also critical for cancer initiation, progression, and metastasis[4].During EMT, epithelial cancer cells progressively lose their apico-basal polarity and cell junctions to acquire mesenchymal cell traits characterized by the expression of extracellular matrix (ECM) remodeling components and higher motility.All these events endow the cancer cells with spread properties into the adjacent tissue and distance into secondary tissues.As a dynamic reversible process, EMT generates a continuum of cells with intermediate,hybrid epithelial, and mesenchymal phenotypes.Cancer cell plasticity through EMT shapes a tumor immune microenvironment favorable to cancer progression by attracting immunosuppressive cells including myeloid-derived suppressor cells (MDSC), Tregs, M2 macrophages, and by increasing the expression of inhibitory immune checkpoints such as PD-1/PD-L-1.Correlative immunohistochemical analyses of EMT and immune markers in a large diversity of human solid cancers are in favor of an interplay between cell plasticity and immunosuppressive TME.In lung adenocarcinomas that display an EMT phenotype, the mesenchymal status of the tumor cells correlates with an increased expression of immune checkpoint molecules, including PD-L1, PD-L2, PD-1, TIM-3, B7-H3 (CD276), BTLA and CTLA-4[5].Similarly, the expression of the metalloproteinase MMP-13 and TWIST1, two EMT markers, is associated with the expression of CTLA-4/PD-1/PD-L1/TIM-3/LAG-3 in esophageal squamous cell carcinoma[6].In ovarian, prostate, and lung cancers, EMT signature correlates with a higher expression of immune checkpoint proteins, increased infiltration of immunosuppressive cells Tregs and M2 macrophages, and a lower CD8+T cells infiltration[5,7-9].A pan-cancer EMT analysis of The Cancer Genome Atlas (TCGA) dataset has evidenced that EMT-high tumors (mesenchymal-like) have a higher immunosuppressive TME compared to EMT-low (epithelial-like) tumors[7].EMT-high tumors are distinguished by the infiltration of tumor-associated macrophages (TAM), the overexpression of immune checkpoint molecules, the upregulation of immune inhibitory cytokines TGF-β1 and IL10, and the enrichment of inflammatory and exhausted CD8+T-cell signatures[10,11].Similar results were found in colorectal cancer (CRC).In conclusion, according to several cancer analyses from public and non-public datasets, there is a positive interdependence between the EMT status of a tumor and its immunosuppressive nature.This correlative statement may serve to identify potential biomarkers and to stratify patients for personalized treatments with immune checkpoint inhibitors or other immunotherapy approaches.

    Mechanistically, EMT is governed by a panel of transcription factors (i.e., EMT-TF) that regulate the expression of epithelial and mesenchymal markers, in negative and positive ways, respectively.The most known EMT-TFs include SNAl1/2, ZEB1/2, and TWIST1/2.Besides transcription factors, tumor cells produce many different soluble autocrine and paracrine factors that trigger EMT directly or indirectlyviathe stromal (CAF) or immune cells[12].For instance, TGF-β1 is a pleiotropic cytokine with multiple biological effects in cancer, either an antitumoral role in the early stages of carcinogenesis, or a pro-tumoral function in later stages.In the latter case, the cytokine is by far a well-known EMT inducer produced by both tumor and TME cells[12].TGF-β1 signaling drives tumor cell plasticity by inducing mesenchymal features along with stemness traits, leading to cell invasion and resistance to anti-cancer drugs.In addition,TGF-β1 shapes an immune-suppressive TME by upregulating the expression of immune checkpoints and attracting immunosuppressive cells.TGF-β1 may also affect immune surveillance by decreasing immunoproteasome, which is a process generating peptides binding to HLA I molecules to facilitate antigen presentation to CD8+T cells[13].Extracellular cues emerging from acellular components of TME also regulate EMT.Indeed, ECM molecules or ECM remodeling proteins activate intracellular signaling pathways followed by EMT-TF activation to drive EMT[12].The underlying molecular mechanisms at the origin of the interplay between EMT and immunosuppression have partly been identified.SNAI1, ZEB1, and TWIST1 are transcription factors governing EMT that also regulate antitumor immune responses.Beyond the regulation of the expression of epithelial and mesenchymal markers, these transcription factors regulate the expression of inhibitory immune checkpoints and soluble factors that attract immunosuppressive cells[14].A summary of these regulations is provided in the next chapter.

    REGULATION OF TUMOR IMMUNE MICROENVIRONMENT BY EPITHELIALMESENCHYMAL TRANSITION-INDUCING TRANSCRIPTION FACTORS

    SNAI1

    SNAI1 regulates the expression of thrombospondin 1 (TSP1) in melanoma cells, which is a secreted matrix protein that promotes Tregs infiltration and impairs dendritic cell (DC) functions[15].Cancer cells expressing SNAI1 release chemokine ligand 2 (CCL2)/monocyte chemoattractant protein 1, (MCP1) and lipocalin 2(LCN2).Together, CCL2 and lipocalin 2 stimulate regulatory dendritic cells (DCreg), which display an immunosuppressive activity, by decreasing the expression of costimulatory molecules (e.g., HLA-DR) and increasing the expression of immunosuppressive molecules (e.g., PD-L1) in human peripheral blood mononuclear cells (PBMCs).The CCL2/LCN2-induced DCreg cells subsequently trigger the proliferation of immunosuppressive CD4+/FOXP3+Treg cells and impair tumor-specific cytosolic T cells (CTL)induction[16].In breast cancer cells, SNAI1 induces mesenchymal and stemness features that alter the susceptibility of cancer cells to T-cell-mediated immune surveillance through an autophagy mechanism[17].Additionally, SNAI1 stimulates the expression of PD-L1 at the surface of breast cancer cellsviaa posttranslational upregulation of proteins containing the CKLF-like MARVEL transmembrane (CMTM) 6 and 7, leading to immune evasion[18].In the transgenic MMTV-PyMT mouse model of breast adenocarcinoma,SNAI1highmesenchymal cancer cells exhibited an increased Tregs infiltration and a M2 macrophage polarization compared to SNAI1lowepithelial cancer cells and displayed high resistance to anti-CTLA-4 treatment[19].Overexpression of SNAI1 or ZEB1 in breast cancer cells leads to an increased expression of CD47, a macrophage immune checkpoint protein also considered as a “don’t eat me” signal that suppresses macrophage phagocytic activity, preventing cancer cell death from macrophages.It has been shown that both transcription factors SNAI1 and ZEB1 directly bind to two E-boxes located on theCD47gene promoter.The analysis of ChIP-seq data performed in mice breast tumors showed that SNAI1 can bind to many more genes; 89 immunomodulatory genes were identified, including the promoters ofNt5e(coding CD73),Csf1andSpp1genes[20].SNAI1 regulates the expression of other immunosuppressive factors including CXCL1 and CXCL2, two chemokines that attract the immunosuppressive cells MDSCs to the tumorviaCXCR2[21].Post-translational modification of SNAI1 by CREB-binding protein (CBP) prevents the repressor complex formation and induces the transcription ofTNFA,CCL2, andCCL5, promoting the recruitment of TAM and tumor progression[22].In humans, analysis of TCGA and METABRIC data sets from breast cancer patients highlighted a correlation between CD47, SNAI1, and vimentin[23].

    ZEB1

    In breast cancer and non-small-cell lung cancer (NSCLC) cells, ZEB1 upregulates PD-L1 expression by downregulating miR-200, a well-known repressor of PD-L1 expression[11].By indirectly upregulating PD-L1,ZEB1 leads to the exhaustion of CD8+T cells[11].However, ZEB1 has been shown to directly regulate PD-L1 expression by binding its gene promoter that contains a ZEB1 binding E-box[24].In colorectal cancer,expression of ZEB1 positively correlates with PD-L1[25].In patients, co-expression of ZEB1 and PD-L1 is associated with a higher cervical lymph node metastasis and a lower survival rate in oral squamous cell carcinoma[26].ZEB1 also induces the expression of CD47 in cancer-invading cells (i.e., mesenchymal-like cells), driving the M2 polarization of adjacent TAMs in the lung adenocarcinoma mouse model.Thus, ZEB1 reprograms the immune microenvironment surrounding invading clusters[24].ZEB1 impacts CD70 expression in lung cancer mesenchymal cell lines; CD70 belongs to the tumor necrosis factor (TNF)superfamily, and its expression in T cells limits their expansion.In mesenchymal NSCLC patient samples,CD70 is overexpressed and positively associated with decreased CD3+and CD8+T-cell infiltration and increased T-cell exhaustion markers[27].Recently, Caramel and Coll.have nicely demonstrated that ZEB1 expression in melanoma cells is associated with a decreased CD8+T-cell infiltration.They show that ZEB1 directly represses the secretion of T cell-attracting chemokines, including CXCL10, leading to resistance against immune checkpoint inhibitors[28].

    TWIST1

    TWIST1 has been shown to regulate CSF1 (Colony-stimulating factor-1/MCSF), a TAM chemotactic molecule, through a transcriptional regulation since CSF1 promotor contains TWIST responsive elements[29].Biologically, TWIST1 increases the expression of CSF1, inducing an activation and polarization of TAM[29].In addition to CSF1, TWIST1 regulates CCL2 in human mammary epithelial cells, promoting the attraction of macrophagesin vitroand their infiltrationin vivo[30].In a murine model of MYC-driven hepatocellular carcinoma (HCC), TWIST1 cooperates with MYC to induce a transcriptional program that stimulates the expression of CCL2 and IL13, leading to the recruitment and polarization of TAM[31].

    In conclusion, several EMT-TFs directly or indirectly initiate transcriptional programs that promote the expression of molecules at the origin of an immune permissive TME.

    STEMNESS AND TUMOR IMMUNE MICROENVIRONMENT

    Cancer stem cells (CSCs) are a key component of TME that play important roles in cancer initiation and progression, and therapy resistance.A strong link between CSC and the immune ecosystem has recently been highlighted[32,33].Several immunohistochemistry studies on human samples have demonstrated a good correlation between stemness and immunity markers in tumors.Based on a signature of five stemnessrelated genes, a stemness-related prognostic index (SPI) was calculated in the head and neck squamous cell carcinomas (HNSCC).It was shown that the high-SPI group with poor prognosis had a “cold”immunologic profile, characterized by an increased number of TAMs and CAFs, and a low level of CD8+T and B cells.On the opposite, the SPI-low group of HNSCC displays an increased number of CD8+T cells,aligning the characteristic of inflamed/mesenchymal subtype[34].Based on comprehensive bioinformatic analyses, it has been shown that CRC patients with higher stemness scores exhibited a worse prognosis, a higher immunosuppressive TME, and lower immunotherapeutic responses[35].Several explanations may justify the link between cancer stem cells and immunosuppressive TME.It is known that CSCs express a higher level of PD-L1 than cancer cells, with the existence of a positive association between CSC expansion and a high PD-L1 expression in TME.CSCs also express B7.1 (CD80), another antitumor checkpoint, and CD47.Together, PD-L1, CD80, and CD47 prevent an antitumor immune response.CSCs are also characterized by a low expression of major histocompatibility complex-1 (MHC-1) molecules or antigen processing and presentation machinery, which contributes to lower immunogenicity in these cells, enabling CSCs to escape the immune system[36,37].In summary, CSCs regulate the TME by inhibiting the antitumor immunity; they suppress CD8+T cell infiltration and promote the recruitment of type 2 macrophages (M2).Furthermore, by recruiting macrophages, CSCs build a niche for maintaining their stemness features[38].

    EMT, STEMNESS, AND IMMUNE MICROENVIRONMENT IN CHOLANGIOCARCINOMA

    CCA contains a high contingency of CSCs, i.e., 30%, and many cancer cells express epithelial and mesenchymal markers[39-42].Although a link between EMT and stemness is well established in this tumor with major consequences on tumor progression and drug resistance[43-45], there are few studies related to cancer cell plasticity and immune evasion in CCA.The first study is related to atypical protein kinase C-iota(aPKC-?)[46].Overexpression of aPKC-? in malignant CCA cells promotes EMT by upregulating SNAI1 expressionviathe phosphorylation of the transcription factor Sp1, providing cells with mesenchymal-like features.Within a mesenchymal phenotype, tumor cells indirectly induce Treg‐like cells through other immune cells or by secreting immunosuppressive cytokines, partly mediated by Treg‐inducible cytokines such as IL‐2 and TGF‐β1[46].More recently, it has been demonstrated that CCA malignant cells with high stemness traits express a lower level of MHC-2 molecules than tumor cells with low stemness features[37].In addition, high stemness malignant cells express high levels of inflammatory factors, contributing to immune evasion[47].

    Mutual crosstalk between CSCs and TAMs has been emphasized in CCA[48-51].The two cell types are important CCA cell contingents comprising 30% CSCs and 10% TAMs[39,52].Recently, it has been demonstrated that CSCs derived from CCA cell lines (HuCC-T1 or SB1) express CD11b, a surface marker for macrophages, leading to increased infiltration of macrophages in CSCs-derived tumors in immunodeficient mice[49].CSCs from CCA also produce soluble molecules involved in the differentiation,activation, and recruitment of macrophages[48], enabling the formation of a tumorigenic niche essential for maintaining CSC characteristics[38,49].Among these molecules, IL13, IL34 and osteoactivin have been identified in the CSC secretome at the origin of macrophagic-based niche[48].Furthermore, macrophages produce and secrete TGF-β1 promoting EMT in CCA cellsviaa Smad2/3-GLI2 signaling pathway[50,53].As previously mentioned, TGF-β1 is a prototypic inducer of EMT, which displays immunosuppressive properties[54].In addition to macrophages, CAFS produce pleiotropic factors attracting immune suppressive cells such as MDSCs.By recruiting MDSCs through a 5-LO/LTB4-BLT2 axis, CAFs contribute to increasing the stemness of malignant cells[55,56].

    With the advent of single-cell RNA sequencing, dissecting the TME of CCA has shed light on information regarding TME cell populations and malignant cell heterogeneity.A molecular classification of intrahepatic-CCA (iCCA) based on stroma, tumor, and immune microenvironment elements has evidenced a hepatic stem-like class enriched in M2-like macrophage[51].In peripheral small duct type iCCA (iCCApps), tumor cells positive for the inhibitor of DNA binding and differentiation 3 (ID3) were identified; ID3 is known to contribute to the acquisition of a molecular stem cell-like signature[57].Along with ID3, tumor cells express several stemness markers, such as ZEB1 or LGR5.Even if no correlative studies between ID3+and immune cells were performed in this work, iCCAppscontaining CD3+cells display an infiltration of CD3+T cells and CD56+NK cells, less M2-like phenotype macrophages and a better prognosis[57], suggesting that in this specific subtype of iCCA, stemness phenotype is linked to a better antitumor immunity.Of note, further studies are needed to confirm this speculative conclusion.

    In another cancer of the biliary epithelium, gallbladder cancer, the inhibitory immune checkpoints CD73 and PD-L1 are closely associated with both EMT and stemness phenotypes.Knockdown of CD73 or PD-L1 reduced the proliferative and migratory functions of cancer cells, suggesting that CD73 and PD-L1 are two potential targets to consider as therapeutic strategies for treating tumors containing high populations of cells with CSC and EMT features[58].

    CONCLUSION

    Cell plasticity refers to the ability of cells to change their identity and behavior in response to different cues or stimuli.This phenomenon is particularly relevant in cancer, as it plays a crucial role in tumor progression, metastasis, and therapeutic resistance.Cancer cells can undergo various forms of plasticity,allowing them to adapt to different microenvironments and evade the body's immune system.In CCA, the immune landscape is the subject of numerous studies and reviews that describe the immune cells in partnership with other TME cells at the origin of the immunosuppressive environment[59-61].EMT is a key process associated with malignant cell plasticity in tumors.EMT enables malignant epithelial cells to acquire mesenchymal properties, such as enhanced mobility and invasiveness.These transitions facilitate the invasion of cancer cells into surrounding tissues, dissemination to distant sites, and the formation of secondary tumors through a reverse process called mesenchymal to epithelial transition (MET).Besides tumor dissemination, EMT represents a non-genetic adaptive pathway for cells to survive upon therapeutic pressure and to escape the immune system, both adaptive and innate.

    EMT can confer stemness properties to cancer cells, which may also contribute to the loss of immunosurveillance.Thus, cell plasticity including EMT or stemness has become a crucial biological way for malignant cells to evade the anti-cancer immune system.The molecular mechanisms behind this process have started to be elucidated, but this domain of research remains in its early stages in CCA.However, the strong relationship established between cell plasticity and immune TME may have an impact on clinical implications for prognosis evaluation.Indeed, the presence of cancer cells with mesenchymal or CSC markers could be a sign of an immunosuppressive TME by the work of Jobet al., in which they classify iCCA according to a stromal signature[62].The authors established a classification of four immune subtypes.Interestingly, the fourth subtype, which is not an immunogenic subtype, displays a signature of CSC, EMT,and TGF-β1 signaling[62].This classification is therefore important for selecting proper treatments and considering combinatorial therapies.Currently, an immune checkpoint inhibitor, durvalumab, combined with chemotherapy, is administered to CCA patients.Other combination treatments could be considered,such as metronidazole, which reduces the number of stem cells in preclinical models of CCA[63].Further information on various therapeutic approaches to eradicate cancer stem cells in liver is well discussed in this review[41].Strategies targeting EMT regulators could form part of the therapeutic arsenal to reduce the mesenchymal characteristics of cancer cells undergoing EMT and enhance the efficacy of immune checkpoint inhibitors.For instance, anti-vimentin therapies seem promising[64]; in the case of CCA, this could be relevant since vimentin is highly expressed[39,65].In conclusion, little is known about cellular plasticity in CCA and its link with the immune microenvironment.A better understanding of this link could lead to improved CCA patient management, in particular by proposing more effective combination therapies.

    DECLARATIONS

    Authors’ contributions

    Wrote the first version of the article: Fouassier L

    Edited and approved the final version: Minini M, Pavy A, Lekbaby B

    Availability of data and materials

    Not applicable.

    Financial support and sponsorship

    Minini M and Fouassier L received financial support from ITMO Cancer of Aviesan within the 2021-2030 Cancer Control Strategy framework on funds administered by Inserm.

    Conflicts of interest

    All authors declared that there are no conflicts of interest.

    Ethical approval and consent to participate

    Not applicable.

    Consent for publication

    Not applicable.

    Copyright

    ? The Author(s) 2024.

    国产99久久九九免费精品| 免费观看精品视频网站| 欧美日韩福利视频一区二区| 午夜激情福利司机影院| 女生性感内裤真人,穿戴方法视频| 黄网站色视频无遮挡免费观看| 真人做人爱边吃奶动态| 一级毛片精品| 国产亚洲av嫩草精品影院| 又大又爽又粗| 亚洲精品国产精品久久久不卡| 香蕉丝袜av| 69av精品久久久久久| 男人舔女人下体高潮全视频| 精品不卡国产一区二区三区| 一级毛片高清免费大全| 香蕉国产在线看| a在线观看视频网站| 久久久精品国产亚洲av高清涩受| 久久天躁狠狠躁夜夜2o2o| АⅤ资源中文在线天堂| 久久欧美精品欧美久久欧美| 9191精品国产免费久久| 日韩国内少妇激情av| 女性被躁到高潮视频| 老司机在亚洲福利影院| 搡老熟女国产l中国老女人| 亚洲天堂国产精品一区在线| 熟女少妇亚洲综合色aaa.| 18禁国产床啪视频网站| 午夜福利高清视频| 精品人妻1区二区| 亚洲国产精品999在线| 成人国产一区最新在线观看| 亚洲中文字幕一区二区三区有码在线看 | 欧洲精品卡2卡3卡4卡5卡区| 久久国产精品人妻蜜桃| 亚洲av中文字字幕乱码综合 | a级毛片a级免费在线| 久久中文字幕人妻熟女| 久久久久国内视频| 可以在线观看的亚洲视频| 黄片大片在线免费观看| 给我免费播放毛片高清在线观看| 好男人在线观看高清免费视频 | 妹子高潮喷水视频| 国产精品98久久久久久宅男小说| 国产亚洲精品久久久久久毛片| 757午夜福利合集在线观看| 一二三四在线观看免费中文在| 又紧又爽又黄一区二区| 欧美黑人欧美精品刺激| 别揉我奶头~嗯~啊~动态视频| 精品一区二区三区av网在线观看| 又黄又爽又免费观看的视频| 免费观看精品视频网站| 在线av久久热| 国产真实乱freesex| 亚洲精品久久国产高清桃花| 一边摸一边抽搐一进一小说| 久久伊人香网站| 色婷婷久久久亚洲欧美| 亚洲精品久久成人aⅴ小说| 欧美zozozo另类| 国产v大片淫在线免费观看| 成人永久免费在线观看视频| 日韩精品免费视频一区二区三区| 夜夜爽天天搞| 亚洲av电影不卡..在线观看| 激情在线观看视频在线高清| 国产主播在线观看一区二区| 69av精品久久久久久| 午夜福利成人在线免费观看| 亚洲熟妇中文字幕五十中出| 一区福利在线观看| 免费女性裸体啪啪无遮挡网站| e午夜精品久久久久久久| 亚洲中文日韩欧美视频| 97碰自拍视频| 久久久久久久午夜电影| 久久久精品国产亚洲av高清涩受| 99国产精品一区二区三区| 亚洲成人精品中文字幕电影| 免费观看人在逋| 最新在线观看一区二区三区| 中文资源天堂在线| 欧美国产精品va在线观看不卡| 脱女人内裤的视频| 亚洲欧洲精品一区二区精品久久久| 欧美黄色淫秽网站| 国产亚洲欧美98| 欧美大码av| av电影中文网址| 亚洲五月色婷婷综合| 99re在线观看精品视频| 中国美女看黄片| 级片在线观看| 欧美亚洲日本最大视频资源| 国产一区二区在线av高清观看| 精品熟女少妇八av免费久了| 亚洲自偷自拍图片 自拍| 亚洲国产毛片av蜜桃av| 欧美黑人巨大hd| 久久久久精品国产欧美久久久| 在线观看66精品国产| 欧美午夜高清在线| 在线观看日韩欧美| 色综合婷婷激情| 国产野战对白在线观看| 亚洲五月天丁香| 亚洲欧洲精品一区二区精品久久久| 亚洲成人免费电影在线观看| 一个人免费在线观看的高清视频| 国产精华一区二区三区| 性色av乱码一区二区三区2| 琪琪午夜伦伦电影理论片6080| 天堂动漫精品| 黑丝袜美女国产一区| 久久精品成人免费网站| 两人在一起打扑克的视频| 一本精品99久久精品77| 色婷婷久久久亚洲欧美| 男女下面进入的视频免费午夜 | 黄色a级毛片大全视频| 成人av一区二区三区在线看| 免费看美女性在线毛片视频| www.熟女人妻精品国产| 婷婷精品国产亚洲av| 一区二区三区高清视频在线| 1024香蕉在线观看| 免费搜索国产男女视频| 久久久国产成人精品二区| 天堂影院成人在线观看| 91九色精品人成在线观看| 国产精品1区2区在线观看.| 老熟妇仑乱视频hdxx| www日本黄色视频网| 一二三四社区在线视频社区8| 免费观看人在逋| 两性夫妻黄色片| 免费看日本二区| 久久久久精品国产欧美久久久| 国产v大片淫在线免费观看| 亚洲七黄色美女视频| 亚洲专区中文字幕在线| 亚洲国产日韩欧美精品在线观看 | 亚洲人成电影免费在线| 国产人伦9x9x在线观看| 国产免费男女视频| 免费电影在线观看免费观看| 免费在线观看黄色视频的| 在线观看舔阴道视频| 国产在线观看jvid| 一区二区三区精品91| 麻豆一二三区av精品| 精品久久久久久,| 欧美黑人巨大hd| 精品国产乱子伦一区二区三区| 日本五十路高清| 亚洲一码二码三码区别大吗| 免费观看精品视频网站| 男女下面进入的视频免费午夜 | 757午夜福利合集在线观看| 午夜免费观看网址| 国产视频内射| 精品国产超薄肉色丝袜足j| 视频区欧美日本亚洲| 亚洲成国产人片在线观看| 午夜激情av网站| 亚洲国产欧洲综合997久久, | 一区二区日韩欧美中文字幕| 国产麻豆成人av免费视频| 日本熟妇午夜| 88av欧美| 校园春色视频在线观看| 亚洲专区中文字幕在线| 免费看十八禁软件| 久久国产亚洲av麻豆专区| 午夜影院日韩av| 最近最新免费中文字幕在线| 欧美日本视频| 波多野结衣高清作品| 欧美丝袜亚洲另类 | 国产伦一二天堂av在线观看| 日韩欧美三级三区| 成人三级做爰电影| 老熟妇仑乱视频hdxx| 亚洲七黄色美女视频| 黑人欧美特级aaaaaa片| 大型黄色视频在线免费观看| 十八禁网站免费在线| av超薄肉色丝袜交足视频| 桃色一区二区三区在线观看| 中文在线观看免费www的网站 | 亚洲欧美精品综合久久99| 一进一出抽搐动态| 成人欧美大片| av天堂在线播放| а√天堂www在线а√下载| 亚洲国产中文字幕在线视频| 变态另类成人亚洲欧美熟女| 国产精品久久久久久精品电影 | 麻豆成人av在线观看| 他把我摸到了高潮在线观看| 一级片免费观看大全| 国产久久久一区二区三区| 亚洲一区中文字幕在线| av中文乱码字幕在线| 精品乱码久久久久久99久播| 午夜福利在线观看吧| 特大巨黑吊av在线直播 | 亚洲五月天丁香| 精品久久久久久久末码| 99精品久久久久人妻精品| 欧美成人免费av一区二区三区| 亚洲国产欧美网| 久久欧美精品欧美久久欧美| 国产欧美日韩一区二区三| 国产精品一区二区三区四区久久 | 成年女人毛片免费观看观看9| 黑人操中国人逼视频| 天天一区二区日本电影三级| 欧美+亚洲+日韩+国产| 视频区欧美日本亚洲| 亚洲一卡2卡3卡4卡5卡精品中文| 脱女人内裤的视频| 久久精品人妻少妇| 欧美激情极品国产一区二区三区| 操出白浆在线播放| 啦啦啦韩国在线观看视频| 夜夜看夜夜爽夜夜摸| 亚洲,欧美精品.| 午夜精品久久久久久毛片777| 一级毛片精品| 亚洲成人精品中文字幕电影| 国产高清有码在线观看视频 | 无人区码免费观看不卡| 国产亚洲精品av在线| 丁香欧美五月| 免费看美女性在线毛片视频| 亚洲免费av在线视频| 好看av亚洲va欧美ⅴa在| 十分钟在线观看高清视频www| 一本大道久久a久久精品| 99re在线观看精品视频| 最近最新免费中文字幕在线| 国产高清videossex| 精品国产超薄肉色丝袜足j| 哪里可以看免费的av片| 国产麻豆成人av免费视频| 窝窝影院91人妻| 成人国产一区最新在线观看| 久久中文字幕人妻熟女| 老司机午夜福利在线观看视频| 白带黄色成豆腐渣| 18禁国产床啪视频网站| 男人操女人黄网站| 国产成人av激情在线播放| 国产99白浆流出| 欧美激情极品国产一区二区三区| 三级毛片av免费| av电影中文网址| 久久人人精品亚洲av| 日韩视频一区二区在线观看| 无人区码免费观看不卡| 亚洲av片天天在线观看| 村上凉子中文字幕在线| 亚洲一码二码三码区别大吗| 久久久久精品国产欧美久久久| 国产午夜福利久久久久久| 久久精品影院6| 欧美色欧美亚洲另类二区| 女性被躁到高潮视频| 国产主播在线观看一区二区| 欧美成人性av电影在线观看| 99热6这里只有精品| 国产1区2区3区精品| 身体一侧抽搐| 99热只有精品国产| 日韩大码丰满熟妇| 夜夜躁狠狠躁天天躁| 最好的美女福利视频网| 欧美成人性av电影在线观看| av片东京热男人的天堂| 免费一级毛片在线播放高清视频| 国产一区二区三区视频了| 一区福利在线观看| 成在线人永久免费视频| 久久久国产精品麻豆| 黑丝袜美女国产一区| 十分钟在线观看高清视频www| 麻豆一二三区av精品| 国产精品综合久久久久久久免费| 黄片小视频在线播放| 久久精品国产亚洲av高清一级| 免费看日本二区| 欧美激情高清一区二区三区| 欧美成狂野欧美在线观看| 免费在线观看日本一区| 亚洲成人免费电影在线观看| 色综合站精品国产| 欧美国产日韩亚洲一区| 午夜免费成人在线视频| 一边摸一边抽搐一进一小说| 一级毛片高清免费大全| 国产蜜桃级精品一区二区三区| 男人的好看免费观看在线视频 | 亚洲一码二码三码区别大吗| 久久午夜亚洲精品久久| 人妻丰满熟妇av一区二区三区| 日韩精品青青久久久久久| 18禁美女被吸乳视频| 99热这里只有精品一区 | 操出白浆在线播放| 欧美日韩黄片免| 日本a在线网址| 18禁裸乳无遮挡免费网站照片 | 国产精品爽爽va在线观看网站 | 久久热在线av| 久久婷婷成人综合色麻豆| 99精品欧美一区二区三区四区| 亚洲九九香蕉| 亚洲免费av在线视频| 国产精品乱码一区二三区的特点| 少妇被粗大的猛进出69影院| 午夜精品在线福利| 久久久久久久久中文| 久久狼人影院| 1024手机看黄色片| 91九色精品人成在线观看| 亚洲国产欧洲综合997久久, | 久久人人精品亚洲av| 国产亚洲精品久久久久5区| 很黄的视频免费| 岛国在线观看网站| 99热只有精品国产| 好男人在线观看高清免费视频 | 亚洲精品色激情综合| 午夜激情福利司机影院| 亚洲一区中文字幕在线| 欧美黑人欧美精品刺激| 成年免费大片在线观看| 亚洲一区中文字幕在线| 国产精品久久久av美女十八| 久久精品91无色码中文字幕| 天堂影院成人在线观看| 亚洲午夜精品一区,二区,三区| 一进一出好大好爽视频| 99在线视频只有这里精品首页| 久久精品亚洲精品国产色婷小说| 久久中文看片网| 国产亚洲欧美98| 一区二区三区激情视频| 日韩欧美免费精品| 黄色a级毛片大全视频| 免费电影在线观看免费观看| 人人澡人人妻人| 国产一卡二卡三卡精品| 久久人妻av系列| 18禁国产床啪视频网站| 中文字幕最新亚洲高清| 精品乱码久久久久久99久播| 午夜免费鲁丝| 美女高潮到喷水免费观看| 可以在线观看毛片的网站| 十八禁网站免费在线| 男女那种视频在线观看| АⅤ资源中文在线天堂| 久久青草综合色| 久久精品影院6| 成人18禁在线播放| 亚洲自拍偷在线| 国产熟女午夜一区二区三区| 国产免费男女视频| 久久久水蜜桃国产精品网| 久久久国产成人精品二区| 动漫黄色视频在线观看| av视频在线观看入口| 我的亚洲天堂| 国产又爽黄色视频| 非洲黑人性xxxx精品又粗又长| 成人国产综合亚洲| 美女高潮喷水抽搐中文字幕| 丝袜人妻中文字幕| www国产在线视频色| 人人澡人人妻人| 欧美成人午夜精品| 国产男靠女视频免费网站| 国产精品,欧美在线| 18禁美女被吸乳视频| 欧美丝袜亚洲另类 | 亚洲国产中文字幕在线视频| 婷婷精品国产亚洲av在线| 亚洲五月天丁香| 国产亚洲精品综合一区在线观看 | 欧美成人午夜精品| 国产亚洲欧美在线一区二区| 很黄的视频免费| 国产亚洲欧美精品永久| 成人国语在线视频| 亚洲精品在线美女| 国产亚洲精品久久久久5区| 久久午夜综合久久蜜桃| 欧美又色又爽又黄视频| 在线观看午夜福利视频| 日日爽夜夜爽网站| 美女免费视频网站| 午夜精品在线福利| 婷婷亚洲欧美| 欧美性猛交黑人性爽| 欧美大码av| 国产在线观看jvid| 国产成人av教育| 精品不卡国产一区二区三区| 欧美激情高清一区二区三区| 亚洲最大成人中文| 1024视频免费在线观看| 妹子高潮喷水视频| 三级毛片av免费| 女人高潮潮喷娇喘18禁视频| 亚洲人成伊人成综合网2020| 成人三级黄色视频| √禁漫天堂资源中文www| 久久天堂一区二区三区四区| 看免费av毛片| av在线天堂中文字幕| 99国产精品一区二区三区| 免费搜索国产男女视频| 亚洲电影在线观看av| 欧美人与性动交α欧美精品济南到| 国产精品综合久久久久久久免费| 国产视频内射| 一区福利在线观看| 91老司机精品| 午夜福利免费观看在线| 少妇熟女aⅴ在线视频| 日本 欧美在线| 国产亚洲精品久久久久久毛片| 后天国语完整版免费观看| 一区二区三区高清视频在线| 免费在线观看成人毛片| 亚洲国产看品久久| 级片在线观看| 久久香蕉国产精品| 欧美绝顶高潮抽搐喷水| 亚洲熟妇中文字幕五十中出| 精品国产乱子伦一区二区三区| 亚洲中文av在线| 久久精品国产综合久久久| 黄频高清免费视频| 亚洲中文日韩欧美视频| 中文字幕人妻丝袜一区二区| 国产精品久久电影中文字幕| 亚洲全国av大片| 久久精品成人免费网站| 中文字幕精品免费在线观看视频| 欧美激情极品国产一区二区三区| 久久热在线av| 在线永久观看黄色视频| 久久草成人影院| 亚洲真实伦在线观看| 99精品久久久久人妻精品| 亚洲电影在线观看av| 一区二区三区精品91| 午夜福利高清视频| 精品久久蜜臀av无| 亚洲第一青青草原| 人人妻人人看人人澡| 51午夜福利影视在线观看| 国产黄片美女视频| 麻豆成人午夜福利视频| 午夜福利18| 亚洲精品国产一区二区精华液| 亚洲成人国产一区在线观看| 久久国产亚洲av麻豆专区| 极品教师在线免费播放| 黄色成人免费大全| 免费在线观看黄色视频的| 午夜福利18| www.熟女人妻精品国产| 国产三级黄色录像| 不卡av一区二区三区| 中国美女看黄片| 一进一出抽搐gif免费好疼| 精品无人区乱码1区二区| 美女午夜性视频免费| 伦理电影免费视频| 女生性感内裤真人,穿戴方法视频| 91九色精品人成在线观看| 免费搜索国产男女视频| 亚洲成人久久性| 国产亚洲欧美98| 两个人免费观看高清视频| 啦啦啦观看免费观看视频高清| 欧美性猛交╳xxx乱大交人| 老熟妇乱子伦视频在线观看| 国产熟女午夜一区二区三区| 成人三级黄色视频| 久久热在线av| 国产精品av久久久久免费| 亚洲精品一卡2卡三卡4卡5卡| 久久久国产成人免费| 亚洲自拍偷在线| 级片在线观看| 亚洲人成77777在线视频| 婷婷亚洲欧美| 中文字幕人妻熟女乱码| 中文字幕人成人乱码亚洲影| 怎么达到女性高潮| 国产黄色小视频在线观看| 国产亚洲av高清不卡| 国产真实乱freesex| 12—13女人毛片做爰片一| 好男人在线观看高清免费视频 | 国产精品九九99| 黄色毛片三级朝国网站| 成人免费观看视频高清| 97超级碰碰碰精品色视频在线观看| 黄色成人免费大全| 一本久久中文字幕| 欧美日韩黄片免| 麻豆国产av国片精品| 国产高清视频在线播放一区| 一级作爱视频免费观看| www.自偷自拍.com| 桃色一区二区三区在线观看| 亚洲国产精品sss在线观看| 性欧美人与动物交配| 午夜免费成人在线视频| 久久久国产成人精品二区| 亚洲第一av免费看| 国产久久久一区二区三区| 香蕉av资源在线| 久久久久久久久免费视频了| 19禁男女啪啪无遮挡网站| 一区二区三区国产精品乱码| 叶爱在线成人免费视频播放| 欧美精品啪啪一区二区三区| a级毛片在线看网站| 国产亚洲精品久久久久久毛片| 男人的好看免费观看在线视频 | 午夜福利在线观看吧| 国产视频一区二区在线看| 桃红色精品国产亚洲av| 不卡一级毛片| 国产成人av教育| 免费高清视频大片| 男女下面进入的视频免费午夜 | 法律面前人人平等表现在哪些方面| 国内揄拍国产精品人妻在线 | 女同久久另类99精品国产91| 日韩大码丰满熟妇| 久久久久久免费高清国产稀缺| 一本一本综合久久| 精品电影一区二区在线| bbb黄色大片| 国产三级在线视频| 91麻豆av在线| 香蕉av资源在线| 久久久久免费精品人妻一区二区 | 免费在线观看视频国产中文字幕亚洲| 在线观看免费日韩欧美大片| 美女大奶头视频| 脱女人内裤的视频| 母亲3免费完整高清在线观看| 嫩草影视91久久| 高清在线国产一区| 叶爱在线成人免费视频播放| 久久久久久免费高清国产稀缺| 精品久久蜜臀av无| 亚洲精品国产精品久久久不卡| 国产精品一区二区精品视频观看| 午夜老司机福利片| 宅男免费午夜| 日韩国内少妇激情av| 欧美日韩一级在线毛片| 久久精品夜夜夜夜夜久久蜜豆 | 俺也久久电影网| xxxwww97欧美| 神马国产精品三级电影在线观看 | 日韩成人在线观看一区二区三区| 午夜亚洲福利在线播放| 又黄又粗又硬又大视频| 亚洲国产精品成人综合色| 熟女电影av网| 在线观看日韩欧美| 久久久国产欧美日韩av| 精品久久久久久成人av| 国产精品一区二区三区四区久久 | 亚洲真实伦在线观看| 色av中文字幕| 他把我摸到了高潮在线观看| 91老司机精品| 成人免费观看视频高清| 又黄又粗又硬又大视频| 成人午夜高清在线视频 | 日本免费a在线| 国产精品99久久99久久久不卡| 给我免费播放毛片高清在线观看| 操出白浆在线播放| 波多野结衣高清无吗| 免费看日本二区| 精品国产美女av久久久久小说| 黑人欧美特级aaaaaa片| 变态另类丝袜制服| 搡老熟女国产l中国老女人| 亚洲av日韩精品久久久久久密| 久久精品成人免费网站| 变态另类成人亚洲欧美熟女| 真人一进一出gif抽搐免费| 亚洲专区中文字幕在线| aaaaa片日本免费| 色在线成人网| 亚洲欧美精品综合久久99| 欧美午夜高清在线|